FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W97512070> ?p ?o ?g. }

• W97512070 endingPage "369" @default.
• W97512070 startingPage "361" @default.
• W97512070 abstract "Multiple myeloma (MM) is an incurable malignancy that is diagnosed in approximately 15,000 people in the United States each year. The novel proteasome inhibitor bortezomib has shown antitumor activity in preclinical studies and has entered clinical trials, with encouraging results to date.We review and summarize preclinical work demonstrating the tumoricidal effects of proteasome inhibition, focusing on the potent and selective proteasome inhibitor bortezomib, the first such agent to progress to clinical trials. We also address the potential for bortezomib as a therapy for MM.In preclinical studies bortezomib appears not only to have activity against MM cells, but also to downregulate protective interactions with bone marrow stromal cells and to inhibit blood vessel development. Proteasome inhibition also has been shown to interfere with protective interactions between MM cells and the bone marrow, and to restrict tumor-associated angiogenesis in preclinical models.Proteasome inhibition is a promising new investigational avenue for cancer therapy. Bortezomib is currently available for the treatment of relapsed and refractory MM. Further trials are underway to assess the safety and efficacy of this agent in MM and a range of other cancers." @default.
• W97512070 created "2016-06-24" @default.
• W97512070 creator A5032464400 @default.
• W97512070 creator A5043526996 @default.
• W97512070 creator A5091207345 @default.
• W97512070 date "2003-09-01" @default.
• W97512070 modified "2023-10-10" @default.
• W97512070 title "Bortezomib (PS-341): A Novel, First-in-Class Proteasome Inhibitor for the Treatment of Multiple Myeloma and Other Cancers" @default.
• W97512070 cites W1723444490 @default.
• W97512070 cites W1954278762 @default.
• W97512070 cites W1966255005 @default.
• W97512070 cites W1970235416 @default.
• W97512070 cites W1978377409 @default.
• W97512070 cites W1992978957 @default.
• W97512070 cites W2026158949 @default.
• W97512070 cites W2040202840 @default.
• W97512070 cites W2064627520 @default.
• W97512070 cites W2068696470 @default.
• W97512070 cites W2070739194 @default.
• W97512070 cites W2076712307 @default.
• W97512070 cites W2083308557 @default.
• W97512070 cites W2090379314 @default.
• W97512070 cites W2108235071 @default.
• W97512070 cites W2118617212 @default.
• W97512070 cites W2120590293 @default.
• W97512070 cites W2129942567 @default.
• W97512070 cites W2134791874 @default.
• W97512070 cites W2148975776 @default.
• W97512070 cites W2166987747 @default.
• W97512070 cites W2169295136 @default.
• W97512070 cites W2172184160 @default.
• W97512070 cites W2330374913 @default.
• W97512070 cites W2332701617 @default.
• W97512070 doi "https://doi.org/10.1177/107327480301000502" @default.
• W97512070 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14581890" @default.
• W97512070 hasPublicationYear "2003" @default.
• W97512070 type Work @default.
• W97512070 sameAs 97512070 @default.
• W97512070 citedByCount "260" @default.
• W97512070 countsByYear W975120702012 @default.
• W97512070 countsByYear W975120702013 @default.
• W97512070 countsByYear W975120702014 @default.
• W97512070 countsByYear W975120702015 @default.
• W97512070 countsByYear W975120702016 @default.
• W97512070 countsByYear W975120702017 @default.
• W97512070 countsByYear W975120702018 @default.
• W97512070 countsByYear W975120702019 @default.
• W97512070 countsByYear W975120702020 @default.
• W97512070 countsByYear W975120702021 @default.
• W97512070 countsByYear W975120702022 @default.
• W97512070 countsByYear W975120702023 @default.
• W97512070 crossrefType "journal-article" @default.
• W97512070 hasAuthorship W97512070A5032464400 @default.
• W97512070 hasAuthorship W97512070A5043526996 @default.
• W97512070 hasAuthorship W97512070A5091207345 @default.
• W97512070 hasConcept C126322002 @default.
• W97512070 hasConcept C143998085 @default.
• W97512070 hasConcept C16930146 @default.
• W97512070 hasConcept C27740335 @default.
• W97512070 hasConcept C2776364478 @default.
• W97512070 hasConcept C2777478702 @default.
• W97512070 hasConcept C2778367456 @default.
• W97512070 hasConcept C2780007613 @default.
• W97512070 hasConcept C502942594 @default.
• W97512070 hasConcept C535046627 @default.
• W97512070 hasConcept C71924100 @default.
• W97512070 hasConcept C86803240 @default.
• W97512070 hasConcept C95444343 @default.
• W97512070 hasConcept C98274493 @default.
• W97512070 hasConceptScore W97512070C126322002 @default.
• W97512070 hasConceptScore W97512070C143998085 @default.
• W97512070 hasConceptScore W97512070C16930146 @default.
• W97512070 hasConceptScore W97512070C27740335 @default.
• W97512070 hasConceptScore W97512070C2776364478 @default.
• W97512070 hasConceptScore W97512070C2777478702 @default.
• W97512070 hasConceptScore W97512070C2778367456 @default.
• W97512070 hasConceptScore W97512070C2780007613 @default.
• W97512070 hasConceptScore W97512070C502942594 @default.
• W97512070 hasConceptScore W97512070C535046627 @default.
• W97512070 hasConceptScore W97512070C71924100 @default.
• W97512070 hasConceptScore W97512070C86803240 @default.
• W97512070 hasConceptScore W97512070C95444343 @default.
• W97512070 hasConceptScore W97512070C98274493 @default.
• W97512070 hasIssue "5" @default.
• W97512070 hasLocation W975120701 @default.
• W97512070 hasLocation W975120702 @default.
• W97512070 hasOpenAccess W97512070 @default.
• W97512070 hasPrimaryLocation W975120701 @default.
• W97512070 hasRelatedWork W1966528856 @default.
• W97512070 hasRelatedWork W1984437179 @default.
• W97512070 hasRelatedWork W2063424779 @default.
• W97512070 hasRelatedWork W2089743544 @default.
• W97512070 hasRelatedWork W2297945252 @default.
• W97512070 hasRelatedWork W2321752808 @default.
• W97512070 hasRelatedWork W2417132786 @default.
• W97512070 hasRelatedWork W3029266790 @default.
• W97512070 hasRelatedWork W3032571198 @default.
• W97512070 hasRelatedWork W3032840474 @default.

• next